tm
Seeing Is Believing
tm
Seeing Is Believing
PBLA is currently covered by 3 analysts
Panbela Therapeutics's activity chart (see below) currently has 0 price targets and 9 ratings on display. The stock rating distribution of PBLA is 12.5% HOLD and 87.5% BUY.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 39.67 days.
Highest price target for PBLA is $5760, Lowest price target is $1.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH MKM on 05-Feb-2024. First documented stock forecast 10-Mar-2021.
Currently out of the existing stock ratings of PBLA, 1 are a HOLD (12.5%), 7 are a BUY (87.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$25
2 years 7 months 27 days ago
(05-Feb-2024)
2/2 (100%)
$4.8 (23.76%)
26
Buy
$16
$14.78 (1211.48%)
$16
3 years 1 months 21 days ago
(11-Aug-2023)
3/3 (100%)
$-16.4 (-50.62%)
93
Buy
3 years 6 months 12 days ago
(20-Mar-2023)
0/1 (0%)
$4320 (81.82%)
What is PBLA (Panbela Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on PBLA (Panbela Therapeutics)?
Which analyst has the current lower performing score on PBLA (Panbela Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PBLA (Panbela Therapeutics)?
Which analyst is the currently most bullish on PBLA (Panbela Therapeutics)?
Which analyst is the currently most reserved on PBLA (Panbela Therapeutics)?
